The association between brain-derived neurotrophic factor (BDNF) and systemic lupus erythematosus (SLE) is controversial, and no study investigated the clinical associations of BDNF in patients with childhood onset systemic lupus erythematosus (cSLE). In this study, we aimed to investigate the serum levels of BDNF in patients with cSLE and examine whether a relationship of BDNF exists among depression, anxiety, and sleep quality.
Methods
Thirty patients and age-sex matched healthy controls were included. Depression, anxiety, sleep quality and quality of life were assessed by relevant questionnaires. Disease activity was assessed according to the SLE disease activity index (SLEDAI) and serum BDNF level was measured by the enzyme-linked immunosorbent assay method.
Results
Serum BDNF level was significantly lower in cSLE patients than healthy controls (21981 vs 29905 pg/mL, p = 0.001) and significantly decreased level was observed in active cSLE (SLEDAI >0), then those with SLEDAI = 0 (17110 vs 26852 pg/mL, p = 0.005). Although the scores of the depression, anxiety, sleep quality and quality of life questionnaires were strongly correlated with each other, no correlation was observed with serum BDNF levels.
Conclusions
In patients with cSLE, serum level of BDNF was significantly decreased compared to healthy controls. Our results suggest that serum BDNF levels were not associated with the presence of anxiety, depression and poor sleep quality and might be dictated by the pathophysiological process of SLE rather than mood disorders.
KamphuisSSilvermanED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol2010; 6: 538–546.
2.
BrunnerHIGladmanDDIbañezD, et al.Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum2008; 58: 556–562.
3.
ZhangLFuTYinR, et al.Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry2017; 17: 70.
4.
CintrónDAlanisJMÁlvarez-VillalobosN, et al.A systematic review of pharmacological therapies and their effectiveness on health-related quality of life outcomes in patients with juvenile-onset systemic lupus erythematosus. Lupus2020; 29: 303–310.
5.
QuilterMCHirakiLTKorczakDJ. Depressive and anxiety symptom prevalence in childhood-onset systemic lupus erythematosus: a systematic review. Lupus2019; 28: 878–887.
6.
DonnellyCCunninghamNJonesJT, et al.Fatigue and depression predict reduced health-related quality of life in childhood-onset lupus. Lupus2018; 27: 124–133.
7.
RahmaniMRahmaniFRezaeiN. The brain-derived neurotrophic factor: missing link between sleep deprivation, insomnia, and depression. Neurochem Res2020; 45: 221–231.
8.
MartinowichKManjiHLuB. New insights into BDNF function in depression and anxiety. Nat Neurosci2007; 10: 1089–1093.
PetriMOrbaiAMAlarcónGS, et al.Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum2012; 64: 2677–2686.
DubovskyANArvikarSSternTA, et al.The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics2012; 53: 103–115.
13.
ÖyB. Çocuklar için depresyon ölçeği: geçerlik ve güvenirlik çalışması. Türk Psikiyatri Dergisi1991; 2: 132–136.
14.
MemikNÇAğaoğluBCoşkunA, et al.Çocuklar için yaşam kalitesi ölçeğinin 13-18 yaş ergen formunun geçerlik ve güvenilirliği. Türk Psikiyatri Dergisi2007; 18: 353–363.
15.
AğargünMYKaraHAnlarÖ. Pittsburgh uyku kalitesi indeksinin geçerliği ve güvenirliği. Türk Psikiyatri Dergisi1996; 7: 107–115.
16.
BirmaherBBrentDAChiappettaL, et al.Psychometric properties of the screen for child anxiety related emotional disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry1999; 38: 1230–1236.
17.
BuysseDJReynoldsCF3rdMonkTH, et al.The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res1989; 28: 193–213.
18.
VarniJWSeidMKurtinPS. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. Med Care2001; 39: 800–812.
19.
NakahashiTFujimuraHAltarCA, et al.Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Lett2000; 470: 113–117.
20.
ZiemssenTKümpfelTSchneiderH, et al.Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: implications for multiple sclerosis therapy. J Neurol Sci2005; 233: 109–112.
21.
KatsuyamaTTsokosGCMoultonVR. Aberrant T cell signaling and subsets in systemic lupus erythematosus. Front Immunol2018; 9: 1088.
22.
TianBYangCWangJ, et al.Peripheral blood brain-derived neurotrophic factor level and tyrosine kinase B expression on T lymphocytes in systemic lupus erythematosus: implications for systemic involvement. Cytokine2019; 123: 154764.
23.
AlessiHDutraLAMariaLA, et al.Serum BDNF and cognitive dysfunction in SLE: findings from a cohort of 111 patients. Clin Rheumatol2022; 41: 421–428.
24.
Noris-GarcíaEArceSNardinP, et al.Peripheral levels of brain-derived neurotrophic factor and S100B in neuropsychiatric systemic lupus erythematous. Lupus2018; 27: 2041–2049.
25.
Kalinowska-ŁyszczarzAPawlakMAWyciszkiewiczA, et al.Immune cell neurotrophin production is associated with subcortical brain atrophy in neuropsychiatric systemic lupus erythematosus patients. Neuroimmunomodulation2017; 24: 320–330.
26.
TamashiroLFOliveiraRDOliveiraR, et al.Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus. Rheumatology2014; 53: 2182–2190.
27.
IkenouchiAYoshimuraRIkemuraN, et al.Plasma levels of brain derived-neurotrophic factor and catecholamine metabolites are increased during active phase of psychotic symptoms in CNS lupus: a case report. Prog Neuropsychopharmacol Biol Psychiatry2006; 30: 1359–1363.
28.
ZhengQXuM-JChengJ, et al.Serum levels of brain-derived neurotrophic factor are associated with depressive symptoms in patients with systemic lupus erythematosus. Psychoneuroendocrinology2017; 78: 246–252.
29.
WillnerP. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology2005; 52: 90–110.
DumanRSMonteggiaLM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry2006; 59: 1116–1127.
32.
JiLLiliSJingW, et al.Appearance concern and depression in adolescent girls with systemic lupus erythematous. Clin Rheumatol2012; 31: 1671–1675.
33.
DavisAMGrahamTBZhuY, et al.Depression and medication nonadherence in childhood-onset systemic lupus erythematosus. Lupus2018; 27: 1532–1541.
34.
LimLSLefebvreABenselerS, et al.Psychiatric illness of systemic lupus erythematosus in childhood: spectrum of clinically important manifestations. J Rheumatol2013; 40: 506–512.
35.
KohutSAWilliamsTSJayanthikumarJ, et al.Depressive symptoms are prevalent in childhood-onset systemic lupus erythematosus (cSLE). Lupus2013; 22: 712–720.
36.
SamjiHWuJLadakA, et al.Review: mental health impacts of the COVID-19 pandemic on children and youth-a systematic review. Ment Health Child Adolesc Ment Health2022; 27: 173–189.
37.
RacineNMcArthurBACookeJE, et al.Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis. JAMA Pediatr2021; 175: 1142–1150.
38.
WuLShiPLTaoSS, et al.Decreased sleep quality in patients with systemic lupus erythematosus: a meta-analysis. Clin Rheumatol2021; 40: 913–922.
39.
DuXZhaoQZhuangY, et al.Fatigue of systemic lupus erythematosus in China: contributors and effects on the quality of life. Patient Prefer Adherence2018; 12: 1729–1735.
40.
ParekhPJOldfield IvECChallapallisriV, et al.Sleep disorders and inflammatory disease activity: chicken or the egg?Am J Gastroenterol2015; 110: 484–488.
41.
Nowicka-SauerKHajdukAKujawska-DaneckaH, et al.Illness perception is significantly determined by depression and anxiety in systemic lupus erythematosus. Lupus2018; 27: 454–460.
42.
LiTCuiCLiY, et al.The impacts of resilience on the association between illness uncertainty and sleep quality among Chinese women with systemic lupus erythematosus. Clin Rheumatol2020; 39: 1609–1616.
43.
InoueMShiozawaKYoshiharaR, et al.Predictors of poor sleep quality in patients with systemic lupus erythematosus. Clin Rheumatol2017; 36: 1053–1062.
44.
NishichiRNufujiYWashioM, et al.Serum brain-derived neurotrophic factor levels are associated with dyssomnia in females, but not males, among Japanese workers. J Clin Sleep Med2013; 9: 649–654.
45.
Silva JuniorJFEckeliALRibeiroCCC, et al.Influence of excessive daily sleeping and sleep quality on BDNF and NGF serum levels in adolescents. Sleep Med2021; 84: 415–423.
46.
ShiYLiMLiuL, et al.Relationship between disease activity, organ damage and health-related quality of life in patients with systemic lupus erythematosus: a systemic review and meta-analysis. Autoimmun Rev2021; 20: 102691.
47.
MoorthyLNPetersonMGHarrisonMJ, et al.Quality of life in children with systemic lupus erythematosus: a review. Lupus2007; 16: 663–669.
48.
KnightAWeissPMoralesK, et al.Depression and anxiety and their association with healthcare utilization in pediatric lupus and mixed connective tissue disease patients: a cross-sectional study. Pediatr Rheumatol Online J2014; 12: 42.
49.
JonesJTCunninghamNKashikar-ZuckS, et al.Pain, fatigue, and psychological impact on health-related quality of life in childhood-onset lupus. Arthritis Care Res2016; 68: 73–80.
